NEW YORK, May 31 – Motorola has decided to abandon its previously announced plans to exclusively license Molecular Staging’s rolling circle amplification technology for use in its diagnostic nucleic acid bioarrays, a spokeswoman for Molecular Staging said Thursday.

“Motorola does not have an exclusive license to the technology,” a spokeswoman for Molecular Staging said.